ArticleBMC cancer2023

Application of the CDK9 inhibitor FIT-039 for the treatment of KSHV-associated malignancy.

Tetsunori Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.